VLS Vita Life Sciences Limited
Healthcare · Drug Manufacturers - Specialty & Generic
· website
$2.76
52wk 2.27 – 2.84
Overall
82.5
Value
80.3
Growth
69.6
Health
100.0
Quality
85.6
Momentum
76.7
Dividend
82.0
Price
About Vita Life Sciences Limited
Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. Vita Life Sciences Limited was founded in 1947 and is headquartered in Mascot, Australia.
Price analytics
Returns
| 1 day | 0.7% |
| 1 week | 0.0% |
| 1 month | -0.4% |
| 3 months | 12.7% |
| 6 months | 6.2% |
| 1 year | 13.6% |
| 3 years | 62.4% |
Risk
| Volatility (1y ann.) | 36.9% |
| Beta vs ASX 200 | 0.20 |
| Sharpe (1y) | 0.42 |
| VaR 95% (1-day) | -3.5% |
| Max drawdown (1y) | -19.5% |
| Off 1-year high | -2.5% |
Technicals
| RSI(14) | 41 |
| vs 50DMA | 3.3% |
| vs 200DMA | 7.3% |
| Trend | Golden cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
80.3
Trailing P/E
82
Forward P/E
—
PEG ratio
—
EV / EBITDA
77
Price / Book
72
Price / Sales
92
Growth
69.6
Revenue growth (1y)
78
Revenue CAGR (3y)
67
EPS growth (1y)
70
EPS CAGR (3y)
62
Financial Health
100.0
Net debt / EBITDA
100
Interest coverage (EBIT/interest)
100
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow)
85.6
Return on equity
100
Return on assets
100
Operating margin
63
Net margin
77
Cash conversion (OCF / net income)
—
Dividend / Income
82.0
Dividend yield (%)
88
Payout ratio
62
FCF dividend cover
100
Momentum
76.7
6-month return vs ASX 200
79
Price vs 200-day average
74
Price vs 50-day average
67
Position in 52-week range
86
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$149.26M
P/E (trailing)
13.80
P/E (forward)
—
EPS (trailing)
0.20
Dividend yield
5.2%
Payout ratio
70.8%
Beta
0.48
EV / EBITDA
7.82
Price / Book
2.79
ROE
20.6%
Operating margin
15.8%
Net margin
11.6%
Total cash
$33.70M
Total debt
$2.16M
Current ratio
2.82
Debt / Equity
0.04
Free cash flow
$12.50M
Avg volume
12,828
Latest annual results
(FY ending 31 Dec 2025)
- Revenue$93.27M
- Gross profit$57.04M
- Operating income$14.06M
- Net income$10.44M
- Diluted EPS0.18
- Free cash flow$15.86M
- Net debt-$33.17M